{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T08:02:00Z","timestamp":1789891320940,"version":"4.0.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T00:00:00Z","timestamp":1487635200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s11914-017-0347-2","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T05:49:45Z","timestamp":1487656185000},"page":"53-60","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":65,"title":["Current Care and Investigational Therapies in Achondroplasia"],"prefix":"10.1007","volume":"15","author":[{"given":"Sheila","family":"Unger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Bonaf\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvire","family":"Gouze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,21]]},"reference":[{"key":"347_CR1","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3406\/bmsap.1878.9953","volume":"1","author":"JM Parrot","year":"1878","unstructured":"Parrot JM. Sur les malformations achon\u00addroplasiques et le dieu Ptah. Bull Anthropol Paris. 1878;1:196.","journal-title":"Bull Anthropol Paris"},{"key":"347_CR2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/TACG.S51485","volume":"7","author":"PJ Ireland","year":"2014","unstructured":"\u2022 Ireland PJ, Pacey V, Zankl A, Edwards P, Johnston LM, Savarirayan R. Optimal management of complications associated with achondroplasia. Appl Clin Genet. 2014;7:117\u201325. This recent review offers an updated management plan for achondroplasia that included the International Classification of Functioning, Disability, and Health (ICF) model of achondroplasia","journal-title":"Appl Clin Genet"},{"key":"347_CR3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0140-6736(07)61090-3","volume":"370","author":"WA Horton","year":"2007","unstructured":"Horton WA, Hall JG, Hecht JT. Achondroplasia. Lancet. 2007;370:162\u201372.","journal-title":"Lancet"},{"key":"347_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.berh.2007.12.008","volume":"22","author":"G Baujat","year":"2008","unstructured":"Baujat G, Legeai-Mallet L, Finidori G, Cormier-Daire V, Le Merrer M. Achondroplasia. Best Pract Res Clin Rheumatol. 2008;22:3\u201318.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"347_CR5","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1002\/ajmg.a.32485","volume":"146A","author":"DK Waller","year":"2008","unstructured":"Waller DK, Correa A, Vo TM, Wang Y, Hobbs C, Langlois PH, Pearson K, Romitti PA, Shaw GM, Hecht JT. The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US. Am J Med Genet A. 2008;146A:2385\u20139.","journal-title":"Am J Med Genet A"},{"key":"347_CR6","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1002\/ajmg.a.31873","volume":"143A","author":"JE Hoover-Fong","year":"2007","unstructured":"Hoover-Fong JE, McGready J, Schulze KJ, Barnes H, Scott CI. Weight for age charts for children with achondroplasia. Am J Med Genet A. 2007;143A:2227\u201335.","journal-title":"Am J Med Genet A"},{"key":"347_CR7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0022-3476(78)81152-4","volume":"93","author":"WA Horton","year":"1978","unstructured":"Horton WA, Rotter JI, Rimoin DL, Scott CI, Hall JG. Standard growth curves for achondroplasia. J Pediatr. 1978;93:435\u20138.","journal-title":"J Pediatr"},{"key":"347_CR8","first-page":"454","volume":"41","author":"JT Hecht","year":"1987","unstructured":"Hecht JT, Francomano CA, Horton WA, Annegers JF. Mortality in achondroplasia. Am J Hum Genet. 1987;41:454\u201364.","journal-title":"Am J Hum Genet"},{"key":"347_CR9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jbspin.2007.06.007","volume":"75","author":"P Richette","year":"2008","unstructured":"Richette P, Bardin T, Stheneur C. Achondroplasia: from genotype to phenotype. Joint Bone Spine. 2008;75:125\u201330.","journal-title":"Joint Bone Spine"},{"key":"347_CR10","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/371252a0","volume":"371","author":"F Rousseau","year":"1994","unstructured":"Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet JM, Maroteaux P, Le Merrer M, Munnich A. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature. 1994;371:252\u20134.","journal-title":"Nature"},{"key":"347_CR11","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/302000","volume":"63","author":"DJ Wilkin","year":"1998","unstructured":"Wilkin DJ, Szabo JK, Cameron R, Henderson S, Bellus GA, Mack ML, Kaitila I, Loughlin J, Munnich A, Sykes B, Bonaventure J, Francomano CA. Mutations in fibroblast growth-factor receptor 3 in sporadic cases of achondroplasia occur exclusively on the paternally derived chromosome. Am J Hum Genet. 1998;63:711\u20136.","journal-title":"Am J Hum Genet"},{"key":"347_CR12","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1093\/hmg\/ddt260","volume":"22","author":"DN Shinde","year":"2013","unstructured":"Shinde DN, Elmer DP, Calabrese P, Boulanger J, Arnheim N, Tiemann-Boege I. New evidence for positive selection helps explain the paternal age effect observed in achondroplasia. Hum Mol Genet. 2013;22:4117\u201326.","journal-title":"Hum Mol Genet"},{"key":"347_CR13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajhg.2011.12.017","volume":"90","author":"A Goriely","year":"2012","unstructured":"Goriely A, Wilkie AO. Paternal age effect mutations and selfish spermatogonial selection: causes and consequences for human disease. Am J Hum Genet. 2012;90:175\u2013200.","journal-title":"Am J Hum Genet"},{"key":"347_CR14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ajmg.1320590218","volume":"59","author":"IM Orioli","year":"1995","unstructured":"Orioli IM, Castilla EE, Scarano G, Mastroiacovo P. Effect of paternal age in achondroplasia, thanatophoric dysplasia, and osteogenesis imperfecta. Am J Med Genet. 1995;59:209\u201317.","journal-title":"Am J Med Genet"},{"key":"347_CR15","doi-asserted-by":"crossref","unstructured":"Arnheim, N., and Calabrese, P. (2016) Germline stem cell competition, mutation hot spots, genetic disorders, and older fathers. Annu Rev Genomics Hum Genet","DOI":"10.1146\/annurev-genom-083115-022656"},{"key":"347_CR16","first-page":"368","volume":"56","author":"GA Bellus","year":"1995","unstructured":"Bellus GA, Hefferon TW, Ortiz de Luna RI, Hecht JT, Horton WA, Machado M, Kaitila I, McIntosh I, Francomano CA. Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am J Hum Genet. 1995;56:368\u201373.","journal-title":"Am J Hum Genet"},{"key":"347_CR17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/mgg3.96","volume":"2","author":"Y Xue","year":"2014","unstructured":"Xue Y, Sun A, Mekikian PB, Martin J, Rimoin DL, Lachman RS, Wilcox WR. FGFR3 mutation frequency in 324 cases from the international skeletal dysplasia registry. Mol Genet Genomic Med. 2014;2:497\u2013503.","journal-title":"Mol Genet Genomic Med"},{"key":"347_CR18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4103\/0019-5413.50856","volume":"43","author":"R Nahar","year":"2009","unstructured":"Nahar R, Saxena R, Kohli S, Puri R, Verma IC. Molecular studies of achondroplasia. Indian J Orthop. 2009;43:194\u20136.","journal-title":"Indian J Orthop"},{"key":"347_CR19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/pd.4790","volume":"36","author":"L Orhant","year":"2016","unstructured":"Orhant L, Anselem O, Fradin M, Becker PH, Beugnet C, Deburgrave N, Tafuri G, Letourneur F, Goffinet F, Allach El Khattabi L, Leturcq F, Bienvenu T, Tsatsaris V, Nectoux J. Droplet digital PCR combined with minisequencing, a new approach to analyze fetal DNA from maternal blood: application to the non-invasive prenatal diagnosis of achondroplasia. Prenat Diagn. 2016;36:397\u2013406.","journal-title":"Prenat Diagn"},{"key":"347_CR20","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/ajmg.a.37776","volume":"170","author":"SC Shelmerdine","year":"2016","unstructured":"Shelmerdine SC, Brittain H, Arthurs OJ, Calder AD. Achondroplasia: really rhizomelic? Am J Med Genet A. 2016;170:2039\u201343.","journal-title":"Am J Med Genet A"},{"key":"347_CR21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.7863\/jum.1994.13.1.63","volume":"13","author":"ER Guzman","year":"1994","unstructured":"Guzman ER, Day-Salvatore D, Westover T, Rosenberg JC, Beim D, Grabelle H. Prenatal ultrasonographic demonstration of the trident hand in heterozygous achondroplasia. J Ultrasound Med. 1994;13:63\u20136.","journal-title":"J Ultrasound Med"},{"key":"347_CR22","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1542\/peds.2005-1440","volume":"116","author":"TL Trotter","year":"2005","unstructured":"Trotter TL, Hall JG, and American Academy of Pediatrics Committee on, G. Health supervision for children with achondroplasia. Pediatrics. 2005;116:771\u201383.","journal-title":"Pediatrics"},{"key":"347_CR23","unstructured":"Pauli, R. M. (1993) Achondroplasia. In GeneReviews (R) (Pagon, R. A., Adam, M. P., Ardinger, H. H., Wallace, S. E., Amemiya, A., Bean, L. J. H., Bird, T. D., Fong, C. T., Mefford, H. C., Smith, R. J. H., and Stephens, K., eds), Seattle (WA)"},{"key":"347_CR24","doi-asserted-by":"crossref","unstructured":"Miccoli, M., Bertelloni, S., and Massart, F. (2016) Height outcome of recombinant human growth hormone treatment in achondroplasia children: a meta-analysis. Horm Res Paediatr","DOI":"10.1159\/000446958"},{"key":"347_CR25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jor.2015.01.001","volume":"12","author":"J Donaldson","year":"2015","unstructured":"Donaldson J, Aftab S, Bradish C. Achondroplasia and limb lengthening: results in a UK cohort and review of the literature. J Orthop. 2015;12:31\u20134.","journal-title":"J Orthop"},{"key":"347_CR26","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1469-8749.2011.04050.x","volume":"53","author":"PJ Ireland","year":"2011","unstructured":"Ireland PJ, McGill J, Zankl A, Ware RS, Pacey V, Ault J, Savarirayan R, Sillence D, Thompson EM, Townshend S, Johnston LM. Functional performance in young Australian children with achondroplasia. Dev Med Child Neurol. 2011;53:944\u201350.","journal-title":"Dev Med Child Neurol"},{"key":"347_CR27","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1469-8749.2012.04234.x","volume":"54","author":"PJ Ireland","year":"2012","unstructured":"Ireland PJ, Donaghey S, McGill J, Zankl A, Ware RS, Pacey V, Ault J, Savarirayan R, Sillence D, Thompson E, Townshend S, Johnston LM. Development in children with achondroplasia: a prospective clinical cohort study. Dev Med Child Neurol. 2012;54:532\u20137.","journal-title":"Dev Med Child Neurol"},{"key":"347_CR28","doi-asserted-by":"crossref","first-page":"E122","DOI":"10.1111\/jpc.12078","volume":"49","author":"PJ Ireland","year":"2013","unstructured":"Ireland PJ, Ware RS, Donaghey S, McGill J, Zankl A, Pacey V, Ault J, Savarirayan R, Sillence D, Thompson E, Townshend S, Johnston LM. The effect of height, weight and head circumference on gross motor development in achondroplasia. J Paediatr Child Health. 2013;49:E122\u20137.","journal-title":"J Paediatr Child Health"},{"key":"347_CR29","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0022-3476(98)70358-0","volume":"132","author":"PJ Mogayzel Jr","year":"1998","unstructured":"Mogayzel Jr PJ, Carroll JL, Loughlin GM, Hurko O, Francomano CA, Marcus CL. Sleep-disordered breathing in children with achondroplasia. J Pediatr. 1998;132:667\u201371.","journal-title":"J Pediatr"},{"key":"347_CR30","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s11325-010-0432-6","volume":"15","author":"S Afsharpaiman","year":"2011","unstructured":"Afsharpaiman S, Sillence DO, Sheikhvatan M, Ault JE, Waters K. Respiratory events and obstructive sleep apnea in children with achondroplasia: investigation and treatment outcomes. Sleep Breath. 2011;15:755\u201361.","journal-title":"Sleep Breath"},{"key":"347_CR31","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/ajmg.1320320421","volume":"32","author":"JT Hecht","year":"1989","unstructured":"Hecht JT, Horton WA, Reid CS, Pyeritz RE, Chakraborty R. Growth of the foramen magnum in achondroplasia. Am J Med Genet. 1989;32:528\u201335.","journal-title":"Am J Med Genet"},{"key":"347_CR32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/bdra.23210","volume":"100","author":"K Simmons","year":"2014","unstructured":"Simmons K, Hashmi SS, Scheuerle A, Canfield M, Hecht JT. Mortality in babies with achondroplasia: revisited. Birth Defects Res A Clin Mol Teratol. 2014;100:247\u20139.","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"347_CR33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s003810050094","volume":"13","author":"P Erdincler","year":"1997","unstructured":"Erdincler P, Dashti R, Kaynar MY, Canbaz B, Ciplak N, Kuday C. Hydrocephalus and chronically increased intracranial pressure in achondroplasia. Childs Nerv Syst. 1997;13:345\u20138.","journal-title":"Childs Nerv Syst"},{"key":"347_CR34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3171\/jns.1989.71.1.0042","volume":"71","author":"P Steinbok","year":"1989","unstructured":"Steinbok P, Hall J, Flodmark O. Hydrocephalus in achondroplasia: the possible role of intracranial venous hypertension. J Neurosurg. 1989;71:42\u20138.","journal-title":"J Neurosurg"},{"key":"347_CR35","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1308\/003588414X13814021679834","volume":"96","author":"S Mukherjee","year":"2014","unstructured":"Mukherjee S, Pringle C, Crocker M. A nine-year review of medicolegal claims in neurosurgery. Ann R Coll Surg Engl. 2014;96:266\u201370.","journal-title":"Ann R Coll Surg Engl"},{"key":"347_CR36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ajmg.a.37394","volume":"170A","author":"KK White","year":"2016","unstructured":"\u2022\u2022 White KK, Bompadre V, Goldberg MJ, Bober MB, Campbell JW, Cho TJ, Hoover-Fong J, Mackenzie W, Parnell SE, Raggio C, Rapoport DM, Spencer SA, Savarirayan R. Best practices in the evaluation and treatment of foramen magnum stenosis in achondroplasia during infancy. Am J Med Genet A. 2016;170A:42\u201351. This review highlights our lack of knolwedge regarding sudden unexplained death in achondroplasia, interfering with the establishment of a consensus of care","journal-title":"Am J Med Genet A"},{"key":"347_CR37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ajmg.a.37385","volume":"170A","author":"KK White","year":"2016","unstructured":"White KK, Parnell SE, Kifle Y, Blackledge M, Bompadre V. Is there a correlation between sleep disordered breathing and foramen magnum stenosis in children with achondroplasia? Am J Med Genet A. 2016;170A:32\u201341.","journal-title":"Am J Med Genet A"},{"key":"347_CR38","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/ajmg.a.35441","volume":"158A","author":"S Julliand","year":"2012","unstructured":"Julliand S, Boule M, Baujat G, Ramirez A, Couloigner V, Beydon N, Zerah M, di Rocco F, Lemerrer M, Cormier-Daire V, Fauroux B. Lung function, diagnosis, and treatment of sleep-disordered breathing in children with achondroplasia. Am J Med Genet A. 2012;158A:1987\u201393.","journal-title":"Am J Med Genet A"},{"key":"347_CR39","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/BRS.0b013e3181e7cb2a","volume":"36","author":"ES Carlisle","year":"2011","unstructured":"Carlisle ES, Ting BL, Abdullah MA, Skolasky RL, Schkrohowsky JG, Yost MT, Rigamonti D, Ain MC. Laminectomy in patients with achondroplasia: the impact of time to surgery on long-term function. Spine (Phila Pa 1976). 2011;36:886\u201392.","journal-title":"Spine (Phila Pa 1976)"},{"key":"347_CR40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cytogfr.2005.02.003","volume":"16","author":"DM Ornitz","year":"2005","unstructured":"Ornitz DM. FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev. 2005;16:205\u201313.","journal-title":"Cytokine Growth Factor Rev"},{"key":"347_CR41","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1242\/dev.105536","volume":"142","author":"E Kozhemyakina","year":"2015","unstructured":"Kozhemyakina E, Lassar AB, Zelzer E. A pathway to bone: signaling molecules and transcription factors involved in chondrocyte development and maturation. Development. 2015;142:817\u201331.","journal-title":"Development"},{"key":"347_CR42","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1101\/gad.1179104","volume":"18","author":"S Murakami","year":"2004","unstructured":"Murakami S, Balmes G, McKinney S, Zhang Z, Givol D, de Crombrugghe B. Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype. Genes Dev. 2004;18:290\u2013305.","journal-title":"Genes Dev"},{"key":"347_CR43","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.devcel.2007.09.016","volume":"13","author":"CA Frutos de","year":"2007","unstructured":"de Frutos CA, Vega S, Manzanares M, Flores JM, Huertas H, Martinez-Frias ML, Nieto MA. Snail1 is a transcriptional effector of FGFR3 signaling during chondrogenesis and achondroplasias. Dev Cell. 2007;13:872\u201383.","journal-title":"Dev Cell"},{"key":"347_CR44","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1128\/MCB.20.2.516-522.2000","volume":"20","author":"E Monsonego-Ornan","year":"2000","unstructured":"Monsonego-Ornan E, Adar R, Feferman T, Segev O, Yayon A. The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation. Mol Cell Biol. 2000;20:516\u201322.","journal-title":"Mol Cell Biol"},{"key":"347_CR45","first-page":"203","volume":"5","author":"S Garcia","year":"2013","unstructured":"Garcia S, Dirat B, Tognacci T, Rochet N, Mouska X, Bonnafous S, Patouraux S, Tran A, Gual P, Le Marchand-Brustel Y, Gennero I, Gouze E. Postnatal soluble FGFR3 therapy rescues achondroplasia symptoms and restores bone growth in mice. Sci Transl Med. 2013;5:203\u2013124.","journal-title":"Sci Transl Med"},{"key":"347_CR46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0014-5793(02)03255-6","volume":"528","author":"E Monsonego-Ornan","year":"2002","unstructured":"Monsonego-Ornan E, Adar R, Rom E, Yayon A. FGF receptors ubiquitylation: dependence on tyrosine kinase activity and role in downregulation. FEBS Lett. 2002;528:83\u20139.","journal-title":"FEBS Lett"},{"key":"347_CR47","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/j.1460-2075.1996.tb00384.x","volume":"15","author":"MK Webster","year":"1996","unstructured":"Webster MK, Donoghue DJ. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J. 1996;15:520\u20137.","journal-title":"EMBO J"},{"key":"347_CR48","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.cellsig.2008.04.001","volume":"20","author":"C Guo","year":"2008","unstructured":"Guo C, Degnin CR, Laederich MB, Lunstrum GP, Holden P, Bihlmaier J, Krakow D, Cho YJ, Horton WA. Sprouty 2 disturbs FGFR3 degradation in thanatophoric dysplasia type II: a severe form of human achondroplasia. Cell Signal. 2008;20:1471\u20137.","journal-title":"Cell Signal"},{"key":"347_CR49","doi-asserted-by":"crossref","first-page":"R2","DOI":"10.1093\/hmg\/ddv419","volume":"25","author":"KA Klag","year":"2016","unstructured":"\u2022 Klag KA, Horton WA. Advances in treatment of achondroplasia and osteoarthritis. Hum Mol Genet. 2016;25:R2\u20138. This review is of importance as it links achondroplasia and osteoarthritis to elaborate common treatment strategies","journal-title":"Hum Mol Genet"},{"key":"347_CR50","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/mcbr.2001.0306","volume":"4","author":"M Terada","year":"2001","unstructured":"Terada M, Shimizu A, Sato N, Miyakaze SI, Katayama H, Kurokawa-Seo M. Fibroblast growth factor receptor 3 lacking the Ig IIIb and transmembrane domains secreted from human squamous cell carcinoma DJM-1 binds to FGFs. Mol Cell Biol Res Commun. 2001;4:365\u201373.","journal-title":"Mol Cell Biol Res Commun"},{"key":"347_CR51","doi-asserted-by":"crossref","first-page":"5443","DOI":"10.1093\/hmg\/dds390","volume":"21","author":"M Jin","year":"2012","unstructured":"Jin M, Yu Y, Qi H, Xie Y, Su N, Wang X, Tan Q, Luo F, Zhu Y, Wang Q, Du X, Xian CJ, Liu P, Huang H, Shen Y, Deng CX, Chen D, Chen L. A novel FGFR3-binding peptide inhibits FGFR3 signaling and reverses the lethal phenotype of mice mimicking human thanatophoric dysplasia. Hum Mol Genet. 2012;21:5443\u201355.","journal-title":"Hum Mol Genet"},{"key":"347_CR52","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nature13775","volume":"513","author":"A Yamashita","year":"2014","unstructured":"\u2022\u2022 Yamashita A, Morioka M, Kishi H, Kimura T, Yahara Y, Okada M, Fujita K, Sawai H, Ikegawa S, Tsumaki N. Statin treatment rescues FGFR3 skeletal dysplasia phenotypes. Nature. 2014;513:507\u201311. In this paper, the authors very elegantly established induced pluripotent stem cells (iPSCs) using fibroblasts derived from patients. This system can be used to screen drugs that might be used to treat FGFR3 chondrodysplasias","journal-title":"Nature"},{"key":"347_CR53","doi-asserted-by":"crossref","first-page":"990","DOI":"10.18632\/aging.100213","volume":"2","author":"K Yudoh","year":"2010","unstructured":"Yudoh K, Karasawa R. Statin prevents chondrocyte aging and degeneration of articular cartilage in osteoarthritis (OA). Aging (Albany NY). 2010;2:990\u20138.","journal-title":"Aging (Albany NY)"},{"key":"347_CR54","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jor.20953","volume":"28","author":"T Simopoulou","year":"2010","unstructured":"Simopoulou T, Malizos KN, Poultsides L, Tsezou A. Protective effect of atorvastatin in cultured osteoarthritic chondrocytes. J Orthop Res. 2010;28:110\u20135.","journal-title":"J Orthop Res"},{"key":"347_CR55","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10195-012-0200-4","volume":"13","author":"JF Baker","year":"2012","unstructured":"Baker JF, Walsh PM, Byrne DP, Mulhall KJ. Pravastatin suppresses matrix metalloproteinase expression and activity in human articular chondrocytes stimulated by interleukin-1beta. J Orthop Traumatol. 2012;13:119\u201323.","journal-title":"J Orthop Traumatol"},{"key":"347_CR56","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.joca.2015.01.002","volume":"23","author":"JR Bush","year":"2015","unstructured":"Bush JR, Berube NG, Beier F. A new prescription for growth? Statins, cholesterol and cartilage homeostasis. Osteoarthr Cartil. 2015;23:503\u20136.","journal-title":"Osteoarthr Cartil"},{"key":"347_CR57","doi-asserted-by":"crossref","first-page":"e81569","DOI":"10.1371\/journal.pone.0081569","volume":"8","author":"M Matsushita","year":"2013","unstructured":"Matsushita M, Kitoh H, Ohkawara B, Mishima K, Kaneko H, Ito M, Masuda A, Ishiguro N, Ohno K. Meclozine facilitates proliferation and differentiation of chondrocytes by attenuating abnormally activated FGFR3 signaling in achondroplasia. PLoS One. 2013;8:e81569.","journal-title":"PLoS One"},{"key":"347_CR58","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/en.2014-1914","volume":"156","author":"M Matsushita","year":"2015","unstructured":"Matsushita M, Hasegawa S, Kitoh H, Mori K, Ohkawara B, Yasoda A, Masuda A, Ishiguro N, Ohno K. Meclozine promotes longitudinal skeletal growth in transgenic mice with achondroplasia carrying a gain-of-function mutation in the FGFR3 gene. Endocrinology. 2015;156:548\u201354.","journal-title":"Endocrinology"},{"key":"347_CR59","doi-asserted-by":"crossref","first-page":"470","DOI":"10.2174\/138920009788897975","volume":"10","author":"JT Hartmann","year":"2009","unstructured":"Hartmann JT, Haap M, Kopp HG, Lipp HP. Tyrosine kinase inhibitors - a review on pharmacology, metabolism and side effects. Curr Drug Metab. 2009;10:470\u201381.","journal-title":"Curr Drug Metab"},{"key":"347_CR60","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1172\/JCI83926","volume":"126","author":"D Komla-Ebri","year":"2016","unstructured":"Komla-Ebri D, Dambroise E, Kramer I, Benoist-Lasselin C, Kaci N, Le Gall C, Martin L, Busca P, Barbault F, Graus-Porta D, Munnich A, Kneissel M, Di Rocco F, Biosse-Duplan M, Legeai-Mallet L. Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model. J Clin Invest. 2016;126:1871\u201384.","journal-title":"J Clin Invest"},{"key":"347_CR61","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/hmg\/ddr514","volume":"21","author":"A Jonquoy","year":"2012","unstructured":"Jonquoy A, Mugniery E, Benoist-Lasselin C, Kaci N, Le Corre L, Barbault F, Girard AL, Le Merrer Y, Busca P, Schibler L, Munnich A, Legeai-Mallet L. A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse model. Hum Mol Genet. 2012;21:841\u201351.","journal-title":"Hum Mol Genet"},{"key":"347_CR62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/hmg\/ddv441","volume":"25","author":"I Gudernova","year":"2016","unstructured":"Gudernova I, Vesela I, Balek L, Buchtova M, Dosedelova H, Kunova M, Pivnicka J, Jelinkova I, Roubalova L, Kozubik A, Krejci P. Multikinase activity of fibroblast growth factor receptor (FGFR) inhibitors SU5402, PD173074, AZD1480, AZD4547 and BGJ398 compromises the use of small chemicals targeting FGFR catalytic activity for therapy of short-stature syndromes. Hum Mol Genet. 2016;25:9\u201323.","journal-title":"Hum Mol Genet"},{"key":"347_CR63","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1073\/pnas.95.5.2337","volume":"95","author":"M Suda","year":"1998","unstructured":"Suda M, Ogawa Y, Tanaka K, Tamura N, Yasoda A, Takigawa T, Uehira M, Nishimoto H, Itoh H, Saito Y, Shiota K, Nakao K. Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide. Proc Natl Acad Sci U S A. 1998;95:2337\u201342.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"347_CR64","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1073\/pnas.071389098","volume":"98","author":"H Chusho","year":"2001","unstructured":"Chusho H, Tamura N, Ogawa Y, Yasoda A, Suda M, Miyazawa T, Nakamura K, Nakao K, Kurihara T, Komatsu Y, Itoh H, Tanaka K, Saito Y, Katsuki M, Nakao K. Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc Natl Acad Sci U S A. 2001;98:4016\u201321.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"347_CR65","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/nm971","volume":"10","author":"A Yasoda","year":"2004","unstructured":"Yasoda A, Komatsu Y, Chusho H, Miyazawa T, Ozasa A, Miura M, Kurihara T, Rogi T, Tanaka S, Suda M, Tamura N, Ogawa Y, Nakao K. Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat Med. 2004;10:80\u20136.","journal-title":"Nat Med"},{"key":"347_CR66","doi-asserted-by":"crossref","first-page":"E1339","DOI":"10.1152\/ajpendo.00272.2009","volume":"297","author":"T Kake","year":"2009","unstructured":"Kake T, Kitamura H, Adachi Y, Yoshioka T, Watanabe T, Matsushita H, Fujii T, Kondo E, Tachibe T, Kawase Y, Jishage K, Yasoda A, Mukoyama M, Nakao K. Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice. Am J Physiol Endocrinol Metab. 2009;297:E1339\u201348.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"347_CR67","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1210\/en.2008-1676","volume":"150","author":"A Yasoda","year":"2009","unstructured":"Yasoda A, Kitamura H, Fujii T, Kondo E, Murao N, Miura M, Kanamoto N, Komatsu Y, Arai H, Nakao K. Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias. Endocrinology. 2009;150:3138\u201344.","journal-title":"Endocrinology"},{"key":"347_CR68","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1124\/jpet.114.218560","volume":"353","author":"DJ Wendt","year":"2015","unstructured":"Wendt DJ, Dvorak-Ewell M, Bullens S, Lorget F, Bell SM, Peng J, Castillo S, Aoyagi-Scharber M, O\u2019Neill CA, Krejci P, Wilcox WR, Rimoin DL, Bunting S. Neutral endopeptidase-resistant C-type natriuretic peptide variant represents a new therapeutic approach for treatment of fibroblast growth factor receptor 3-related dwarfism. J Pharmacol Exp Ther. 2015;353:132\u201349.","journal-title":"J Pharmacol Exp Ther"},{"key":"347_CR69","unstructured":"Noonberg S. BMN 111: vosoritide for achondroplasia. Biomarin R&D Day. 2016:98\u2013135."},{"key":"347_CR70","doi-asserted-by":"crossref","first-page":"E355","DOI":"10.1210\/jc.2014-2814","volume":"100","author":"RC Olney","year":"2015","unstructured":"Olney RC, Prickett TC, Espiner EA, Mackenzie WG, Duker AL, Ditro C, Zabel B, Hasegawa T, Kitoh H, Aylsworth AS, Bober MB. C-type natriuretic peptide plasma levels are elevated in subjects with achondroplasia, hypochondroplasia, and thanatophoric dysplasia. J Clin Endocrinol Metab. 2015;100:E355\u20139.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-017-0347-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-017-0347-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-017-0347-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T15:46:34Z","timestamp":1719071194000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-017-0347-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,21]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["347"],"URL":"https:\/\/doi.org\/10.1007\/s11914-017-0347-2","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,21]]}}}